(MedPage Today) — For severe chronic rhinosinusitis with nasal polyps, novel stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid, the randomized CROWNS-2 trial showed.
When given in addition to intranasal…
Source link : https://www.medpagetoday.com/allergyimmunology/allergy/117048
Author :
Publish date : 2025-08-18 19:05:00
Copyright for syndicated content belongs to the linked Source.
